Department of Ophthalmology and Visual Science, Hiroshima University Graduate School of Biomedical Sciences, and Department of Ophthalmology, Hiroshima Red Cross and Atomic Bomb Survivors Hospital, Hiroshima, Japan.
Int J Radiat Oncol Biol Phys. 2011 Dec 1;81(5):1394-8. doi: 10.1016/j.ijrobp.2010.07.1983. Epub 2010 Oct 1.
To compare the pterygium recurrence rates after treatment with two different β-radiation doses.
A total of 84 patients with a mean age of 63.0±10.3 years (men, 48 eyes, and women, 47 eyes) and initially treated with β-radiation after pterygium excision were recruited. The mean follow-up period was 49.9±51.3 months. The patients were assigned to two dose groups: a high-dose (40 Gy) or a low-dose (20 Gy) group. The statistical significance of differences in patient age, pterygium size, and interval between surgery and radiotherapy were analyzed in the 20-Gy group using the Cox proportional hazard model at p<.05.
The high- and low-dose groups included 28 and 67 eyes, respectively. Pterygia recurred in 11 eyes, all in the low-dose group. The interval between surgery and radiotherapy was not a significant predictor of recurrence. Smaller pterygia had a lower risk of recurrence than pterygia that had encroached the pupillary area (pterygium located within one-third of the corneal radius from the limbus, corrected hazard ratio [HR], 0.069; 95% confidence interval [CI], 0.006-0.766; p=.030; pterygium extending beyond one-third of the corneal radius, corrected HR, 0.188; 95% CI, 0.018-0.696; p=0.019; and pterygium reaching the pupillary area, corrected HR, 0.184; 95% CI, 0.036-0.929; p=.040). Older age was marginally significant as a negative predictor of recurrence (HR, 0.943; 95% CI, 0.887-1.003; p=.061). No scleromalacia developed during the follow-up period.
β-Radiation at 40 Gy was more efficacious than at 20 Gy in preventing pterygium recurrence without scleromalacia development, particularly for large-size pterygia and those in young patients.
比较两种不同β射线剂量治疗翼状胬肉后的复发率。
共招募了 84 名平均年龄为 63.0±10.3 岁(男性 48 眼,女性 47 眼)的患者,这些患者在翼状胬肉切除术后接受β射线治疗。平均随访时间为 49.9±51.3 个月。患者被分为两组:高剂量(40 Gy)组和低剂量(20 Gy)组。采用 Cox 比例风险模型分析 20 Gy 组中患者年龄、翼状胬肉体积和手术与放疗间隔的差异,p<.05 有统计学意义。
高剂量组和低剂量组分别有 28 眼和 67 眼。11 只眼复发,均在低剂量组。手术与放疗的间隔时间不是复发的显著预测因素。较小的翼状胬肉比侵犯瞳孔区的翼状胬肉有更低的复发风险(位于角膜缘半径内三分之一的翼状胬肉,校正后的危险比[HR],0.069;95%置信区间[CI],0.006-0.766;p=.030;超过角膜缘半径三分之一的翼状胬肉,校正 HR,0.188;95% CI,0.018-0.696;p=0.019;以及到达瞳孔区的翼状胬肉,校正 HR,0.184;95% CI,0.036-0.929;p=.040)。年龄较大是复发的负预测因素(HR,0.943;95% CI,0.887-1.003;p=.061)。在随访期间没有发生巩膜软化。
40 Gy 的β射线在预防翼状胬肉复发方面比 20 Gy 更有效,且不会导致巩膜软化,特别是对于大体积的翼状胬肉和年轻患者。